N-3 fatty acid supplementation mediates lipid profile, including small dense LDL, when combined with statins: a randomized double blind placebo controlled trial

BACKGROUND: Epidemiological and clinical evidence suggests that high-dose intake of omega 3 fatty acids (n-3 FA) have a favorable role in altering serum triglycerides (TG) and non-high density lipoprotein cholesterol (non-HDL-C) when combined with statins in hyperlipidemic patients. Their efficacy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dogay Us, Gediz, Mushtaq, Sohail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434850/
https://www.ncbi.nlm.nih.gov/pubmed/36050695
http://dx.doi.org/10.1186/s12944-022-01686-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434850/
https://www.ncbi.nlm.nih.gov/pubmed/36050695
http://dx.doi.org/10.1186/s12944-022-01686-y

Ejemplares similares